Acambis plc (“Acambis”) (LSE: ACM, NASDAQ: ACAM) announces that Dr Thomas Monath, 65, will retire as Chief Scientific Officer and Executive Director of Acambis at the Annual General Meeting on 23 June 2006. Dr Monath will then serve as a Non- Executive Director of Acambis until 1 September 2006 following which he will provide advice to Acambis from time to time on its smallpox and ChimeriVax vaccines.
